Back
Amicus Therapeutics, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
53
FOLD
Amicus Therapeutics, Inc.
Last Price:
$9.96
Seasonality Move:
-1.54%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAmicus Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 16% based on the past 18 years of stock performance.
-
Amicus Therapeutics, Inc. has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
-
Is Amicus Therapeutics, Inc. Stock Undervalued?The current Amicus Therapeutics, Inc. [FOLD] share price is $9.78. The Score for FOLD is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
FOLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Amicus Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 16% based on the past 18 years of stock performance.
Amicus Therapeutics, Inc. Stock Rating
Buy
53
Amicus Therapeutics, Inc. (FOLD)
is a Buy
Is Amicus Therapeutics, Inc. overpriced?
-
Amicus Therapeutics, Inc. has risen higher in 7 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 38.89%
Amicus Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com
52-Week Data
52-Week High:
10.57
52-Week Low:
5.51
Prediction Charts
Market Cap:
3B
Price in USD:
9.78
Volume:
2.9M
Beta:
0.98
Technical Analysis
SMA50:
8.84
SMA100:
8.02
SMA200:
7.58
52-Wk Change:
-0.1%
Stock Predictions
-
Is Amicus Therapeutics, Inc. stock public?Yes, Amicus Therapeutics, Inc. is a publicly traded company.
-
What is the Amicus Therapeutics, Inc. stock quote today?The Amicus Therapeutics, Inc. stock price is 9.78 USD today.
-
How to buy Amicus Therapeutics, Inc. stock online?You can buy Amicus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-13 | 9.41 | 9.38 | 9.50 | 9.24 |
| Nov-14 | 9.25 | 9.48 | 9.56 | 9.25 |
| Nov-17 | 9.48 | 9.42 | 9.65 | 9.42 |
| Nov-18 | 9.30 | 9.59 | 9.63 | 9.27 |
| Nov-19 | 9.53 | 9.73 | 9.78 | 9.42 |
| Nov-20 | 9.83 | 9.45 | 9.88 | 9.37 |
| Nov-21 | 9.42 | 9.56 | 9.62 | 9.31 |
| Nov-24 | 10.01 | 9.89 | 10.57 | 9.52 |
| Nov-25 | 10.08 | 9.87 | 10.14 | 9.76 |
| Nov-26 | 10.10 | 10.02 | 10.10 | 9.79 |
| Nov-28 | 9.99 | 9.93 | 10.05 | 9.88 |
| Dec-1 | 9.92 | 9.80 | 10.05 | 9.77 |
| Dec-2 | 9.87 | 9.73 | 10.02 | 9.56 |
| Dec-3 | 9.78 | 9.78 | 9.85 | 9.66 |
Amicus Therapeutics, Inc. Earnings
Amicus Therapeutics, Inc. Earnings Report: Per Share Amicus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Amicus Therapeutics, Inc. Forecast Revenue Growth
Amicus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.31 per share.
* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.